The Hamner Institutes For Health Sciences Announces New Board Appointments

The Hamner Institutes for Health Sciences (www.thehamner.org) has announced new additions to its 2008 Board of Directors. New members include Dr. Enriqueta C. Bond, president of The Burroughs Wellcome Fund, Robert C. Eubanks, founder and president of Franklin Street Partners, and Dr. Garheng Kong, general partner at Intersouth Partners. The three additions complete a 2008 Board that includes:

• Dr. Michael P. Czech, University of Massachusetts Medical School
• Dr. Joseph J. DeGeorge, Merck Research Laboratories
• Eugene D. Ervin, Air Products and Chemicals, Inc.
• William D. Johnson, Progress Energy, Inc.
• Dr. James S. McDonald, Schering-Plough Research Institute

The Hamner’s 2008 Board Officers are:
• Chair: Dr. Charles E. Hamner, Hamner Advisory Services, Inc.
• Vice-Chair: Dr. Robert W. Rickard, DuPont SHE & Sustainable Growth Center
• President and CEO: Dr. William F. Greenlee, The Hamner Institutes for Health Sciences
• Treasurer: Dr. John G. Dent, GlaxoSmithKline Consumer Healthcare, retired
• Secretary: Dr. James S. Bus, The Dow Chemical Company
• Assistant Treasurer: Helen N. Schinkel, The Hamner Institutes for Health Sciences

The Hamner Institutes for Health Sciences Board of Directors is responsible for guiding the success of the organization’s mission — to serve as a neutral and independent fourth party, bringing together key stakeholders in academia, industry and regulatory agencies to proactively collaborate on the development of improved chemical risk assessments, as well as new and safer medicines.

Related Links:
www.thehamner.org
www.bwfund.org
www.franklin-street.com
www.intersouth.com

Quotes:
"The combined education, experience and backgrounds of the board is impressive," said Dr. Greenlee, president and CEO of The Hamner Institutes for Health Sciences. "We look forward to collaborating with these new board members in the pursuit of improved public health."

About The Hamner Institutes for Health Sciences:
Located on a 56-acre campus in Research Triangle Park, North Carolina, The Hamner Institutes for Health Sciences is an independent, nonprofit organization that unites academia, the private sector and government to conduct translational research for improved human health assessments. With the ultimate goal of preventing and curing disease, The Hamner offers an open, collaborative and cross-disciplinary approach to strengthen the research investment in biomedical sciences. The Hamner conducts translational research for improved human health through the development of new and safer medicines. CIIT, the flagship institute for The Hamner, has been recognized for more than 30 years as a leader in research in environmental risk assessment and health sciences. For more information, please visit www.thehamner.org or call (919) 558-1200.

Keywords:
The Hamner for Health Sciences, Nonprofit, Dr. William F. Greenlee, Dr. Charles E. Hamner, Environmental Risk Assessment, Biomedical, Biotechnology, Research Triangle Park, RPT, Pharmaceutical Drug Development, Translational Biomedical Sciences, Public Health, Dr. Robert W. Rickard, Dr. John G. Dent, Dr. James S. Bus, Helen N. Schinkel, Dr. Enriqueta C. Bond, Dr. Michael P. Czech, Dr.Robert C. Eubanks, Dr. Joseph J. DeGeorge, Eugene D. Ervin, William D. Johnson, Dr. Garheng Kong, Dr. James S. McDonald, 2008 Board Officers and Directors

Patty Briguglio
MMI Associates, Inc.
919-233-6600
patty@mmimarketing.com
PR Firms Raleigh, NC

(end)